Skip to content

Evacuation Time and Tourniquet Use as Risk Factors for PTSD in Combat-Related Amputation

Evacuation Time and Tourniquet Use as Risk Factors for PTSD in Combat-Related Amputation: A Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07502313
Acronym
EVAC-PTSD Stud
Enrollment
300
Registered
2026-03-30
Start date
2026-03-15
Completion date
2026-11-15
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation, Combat Posttraumatic Stess Disorder, Combat Trauma, PTSD

Keywords

Post-Traumatic Stress Disorder, Combat Trauma, Amputation, Tourniquet Use, Evacuation Time

Brief summary

This study aims to evaluate the relationship between evacuation time, tourniquet use, and the development of post-traumatic stress disorder (PTSD) in patients with combat-related amputations. In the context of modern warfare, prolonged evacuation times and extended tourniquet application may contribute not only to physical injury but also to psychological trauma. The study will prospectively follow patients over 18 months to identify key predictors of PTSD and to assess their interaction.

Detailed description

Combat-related amputations are frequently associated with prolonged evacuation times and the use of hemostatic tourniquets. While these factors are critical for survival, their potential contribution to long-term psychological outcomes remains insufficiently studied. This prospective longitudinal study will investigate how evacuation delays and tourniquet duration influence the development of PTSD symptoms in Ukrainian veterans with limb amputations. The study will also evaluate the interaction between these factors and their cumulative psychological impact. Participants will be followed for 18 months using validated PTSD screening tools, including the PCL-5 questionnaire, combined with retrospective analysis of medical records.

Interventions

None listed

Sponsors

Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Ukrainian veterans with combat-related injury (post-February 2022) * Single limb amputation * Admission to rehabilitation within 2-4 months post-injury * Age ≥18 years * Ability to provide informed consent

Exclusion criteria

* Prior PTSD diagnosis before current injury * Multiple amputations * Rehabilitation duration \>3 months * Return to active military duty before follow-up completion

Design outcomes

Primary

MeasureTime frameDescription
PTSD severity measured by PCL-5 score18 months (baseline, 2, 6, 12, and 18 months follow-up)Severity of post-traumatic stress disorder (PTSD) symptoms will be assessed using the PTSD Checklist for DSM-5 (PCL-5), a validated 20-item self-report questionnaire. Each item is scored on a scale from 0 (not at all) to 4 (extremely), with a total score range of 0 to 80, where higher scores indicate greater symptom severity. The primary outcome will be the total PCL-5 score measured longitudinally to evaluate changes in PTSD symptom severity over time and its association with evacuation time and duration of tourniquet use.

Secondary

MeasureTime frameDescription
Change in PTSD Severity Over TimeBaseline to 18 monthsChange in PTSD symptom severity measured as the difference in total PCL-5 score between baseline and follow-up assessments. This outcome will evaluate the trajectory of PTSD symptoms over time.

Countries

Ukraine

Contacts

CONTACTDmytro Dmytriiev, PhD.Professor
d.dmytriiev@superhumans.com+380674309449

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026